Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-22-000011

Options or other derivatives

  • Chief Scientific Officer acquired 190,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Carter Laura Chief Scientific Officer 2022-01-06 Grant or award · Stock Option (Right to Buy) +190,000 190,000 D: show line 1 in the form
Loading xslF345X03/wf-form4_164184919646960.xml…